Colin provides national oversite to all site quality functions and has recently led the project for the selection, implementation and validation of Slade Health’s electronic quality management system.

Colin’s experience in the manufacture of biological and cytotoxic medicines is focused on compliance to cGMP and PIC/s (Annex 1) manufacturing standards, in TGA licensed organisations.